Michelle Brown

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

Ivan Titov, Richard G. Wunderink, Antoine Roquilly et al. · Clinical Infectious Diseases · 2020 · 213 citations · Full text

Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections

Matthew Sims, Valeri Mariyanovski, Patrick McLeroth et al. · Journal of Antimicrobial Chemotherapy · 2017 · 158 citations · Full text

Evaluation of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children

Henry R. Shinefield, Steve Black, Laura Digilio et al. · The Pediatric Infectious Disease Journal · 2005 · 124 citations

Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19

José Ramón Arribas, Sanjay Bhagani, Suzana M. Lobo et al. · NEJM Evidence · 2021 · 124 citations

Adverse Events, Clinical Infectious Disease, Covid-19 Pandemic +14